Yuchuan Guo

Title: Yuchuan Guo: Innovator in Non-Anticoagulant Heparin Derivatives

Introduction

Yuchuan Guo is a notable inventor based in Alameda, CA, who has made significant contributions to the field of biomedical research. He holds 2 patents that focus on innovative applications of heparin derivatives. His work is particularly relevant in the context of preventing restenosis and other conditions that benefit from antiproliferative activity.

Latest Patents

Guo's latest patents revolve around the development of non-anticoagulant (NAC) forms of heparin. These derivatives exhibit antiproliferative activity concerning smooth muscle cells, making them useful in preventing restenosis. The first patent describes a method for preparing NAC heparin by oxidizing heparin/heparan sulfate to a desired level with periodate, followed by the reduction of the resulting aldehyde groups while preventing depolymerization. The second patent outlines a similar process, where heparin/heparan sulfate is deacetylated and oxidized substantially to completion with periodate, followed by reduction under conditions that also prevent depolymerization.

Career Highlights

Yuchuan Guo is currently associated with Glycomed, Inc., where he continues to advance his research in heparin derivatives. His work has garnered attention for its potential applications in medical treatments and therapies.

Collaborations

Guo collaborates with H Edward Conrad, contributing to the innovative research environment at Glycomed, Inc. Their combined expertise enhances the development of new biomedical solutions.

Conclusion

Yuchuan Guo's contributions to the field of heparin derivatives highlight his role as an influential inventor. His innovative approaches have the potential to significantly impact medical treatments and improve patient outcomes.